← FDA DRUG APPROVALS

FDA NDA · NDA019432

SPECTAMINE

Sponsor: IMP

APPLICATION
NDA019432
TYPE
NDA
ORIGINAL APPROVAL
1987-12-24
LATEST ACTION
1988-07-29
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SPECTAMINEDiscontinued
IOFETAMINE HYDROCHLORIDE I-123 1mCi/ML · INJECTABLE · INJECTION

Approval history

1988-07-29Manufacturing (CMC) · Supplement 1 · standardAP
1987-12-24Type 1 - New Molecular Entity · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →